Cargando…

A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer

This multi-site, double blind, parallel arm, fixed dose, randomised placebo controlled phase III study compared megestrol acetate 480 mg/day with dexamethasone 4 mg/day for their net effects on appetite in people with cancer anorexia. Patients with advanced cancer and anorexia for ≥ 2 weeks with a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Currow, David C., Glare, Paul, Louw, Sandra, Martin, Peter, Clark, Katherine, Fazekas, Belinda, Agar, Meera R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844230/ https://www.ncbi.nlm.nih.gov/pubmed/33510313 http://dx.doi.org/10.1038/s41598-021-82120-8

Ejemplares similares

Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006)

Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma
por: Chow, P K H, et al.
Publicado: (2011)

Megestrol acetate for cachexia–anorexia syndrome. A systematic review
por: Ruiz‐García, Vicente, et al.
Publicado: (2018)

Megestrol Acetate-Induced Symptomatic Hypogonadism in a Male Patient
por: Munshi, Lubna Bashir, et al.
Publicado: (2018)

Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide
por: McCaffrey, Nikki, et al.
Publicado: (2020)

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
por: Gebbia, V., et al.
Publicado: (1996)

Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
por: Hong, Sungwoo, et al.
Publicado: (2013)

A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia
por: Lim, Yu Liang, et al.
Publicado: (2022)

Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: A study protocol (LUANA trial)
por: Sousa, Mariana S., et al.
Publicado: (2023)

New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate
por: Lachowicz, Malwina, et al.
Publicado: (2016)

Exogenous Cushing’s Syndrome, Hypogonadism and Diabetes Secondary to Megestrol Acetate
por: Baby, Merilyn, et al.
Publicado: (2021)

A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol
por: Currow, David, et al.
Publicado: (2017)

Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients
por: Gołębiewska, Justyna E., et al.
Publicado: (2011)

Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
por: Shan, Weiwei, et al.
Publicado: (2014)

Hydrophilic and Functionalized Nanographene Oxide Incorporated Faster Dissolving Megestrol Acetate
por: Islam, Mohammad Saiful, et al.
Publicado: (2021)

Mirtazapine versus Megestrol in the Treatment of Anorexia–Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial
por: Almeida, Olga Laura Sena, et al.
Publicado: (2023)

Study protocol: a phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessness
por: Watts, Gareth J, et al.
Publicado: (2016)

Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension
por: Deschamps, Benoit, et al.
Publicado: (2009)

Megestrol Acetate Induced Paradoxical Embolism in a Sickle Cell Disease Patient
por: Dominguez, Lisette, et al.
Publicado: (2019)

SUN-031 Megestrol Acetate for Bodybuilding Resulting in Abrupt Hypothalamic-Pituitary Dysfunction
por: Lessard, Kimberly Kochersperger, et al.
Publicado: (2020)

Characterizing the Drug-Release Enhancement Effect of Surfactants on Megestrol-Acetate-Loaded Granules
por: Katona, Gábor, et al.
Publicado: (2022)

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma.
por: Wood, L., et al.
Publicado: (1998)

A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients.
por: McMillan, D. C., et al.
Publicado: (1997)

Precipitation Reaction of SDS and Potassium Salts in Flocculation of a Micronized Megestrol Acetate Suspension
por: Hejazi, Seyed Mahdi, et al.
Publicado: (2013)

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss
por: McMillan, D C, et al.
Publicado: (1999)

Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer
por: Wen, Wei, et al.
Publicado: (2017)

Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation
por: Musolino, Vincenzo, et al.
Publicado: (2016)

Long-term efficacy of megestrol acetate and tamoxifen in a recurrent adult granulosa cell tumor of the ovary
por: Moon, Ashley S., et al.
Publicado: (2021)

Megestrol treatment in patients with hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2001)

Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol
por: Matsuoka, Hiromichi, et al.
Publicado: (2022)

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care
por: Penel, N, et al.
Publicado: (2010)

Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state
por: Jang, Kyungho, et al.
Publicado: (2014)

Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process
por: Ha, Eun-Sol, et al.
Publicado: (2015)

Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem
por: La Vecchia, Maria, et al.
Publicado: (2022)

SAT319 Megestrol-induced Adrenal Insufficiency
por: Alcorn, Chris, et al.
Publicado: (2023)

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
por: Wolfe, Cameron R, et al.
Publicado: (2022)

Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
por: Strasser, F, et al.
Publicado: (2008)

Megestrol acetate dispersible tablets with a 5-HT3 receptor antagonist and dexamethasone vs. 5-HT3 receptor antagonist plus dexamethasone, can better control chemotherapy-induced nausea and vomiting: a randomized controlled study
por: Ma, Yijie, et al.
Publicado: (2022)

Pharmacovigilance in hospice/palliative care: net effect of gabapentin for neuropathic pain
por: Sanderson, Christine, et al.
Publicado: (2015)

Chlorhexidine oral rinses for symptomatic COPD: a randomised, blind, placebo-controlled preliminary study
por: Pragman, Alexa A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e36r5h7lsakllcvnj0kpcfh5c3